Los neutrófilos, células de defensa contra infecciones, se transforman en presentadores de antígenos al contacto con TRIMELVax, siendo imprescindibles para su efectividad. El hallazgo, publicado en OncoImmunology y liderado por el Dr. Flavio Salazar, ya derivó en una patente y modificó el protocolo de producción de TAPCells.
El Dínamo
· Jun 16, 2026
· health
· 2 min read
High
Sourcing: Verified
Células inmunes "kamikaze" son clave para vacuna chilena contra melanoma avanzado
Pacientes con melanoma metastásico avanzado sin opciones terapéuticas previas han experimentado remisión de metástasis y lesiones en piel y cerebro con esta terapia.
◉
Business
522 related articles
WTTC to establish permanent Madrid headquarters, hiring 45 internation…
LA RAZÓN · 80% match
Pink Albatross seeks creditor protection as vegan ice cream startup ba…
El Español · 70% match
Orange completes €4.25B acquisition to gain full control of MasOrange
Google News · 70% match
Mr Jeff executives face trial for alleged fraud against Sean Connery F…
El Confidencial · 70% match
Iberdrola celebrates renewable strategy as stock hits record highs
ABC · 70% match
Related Coverage
El Ecosistema Startup · Aug 24
James Dacombe, 25 años: de abandonar la secundaria a multimillonario en chips de IA
James Dacombe, fundador de Olix, se convierte a los 25 años en el multimillonario hecho a sí mismo más joven de Europa t…
Gestión · Aug 23 Manzana Verde apunta a US$10M en facturación para 2027 con expansión de franquiciasManzana Verde, startup peruana de alimentación saludable, alcanzó rentabilidad y planea escalar a US$10 millones de fact…
El Ecosistema Startup · Aug 23 IA para pymes: automatizar sin perder el control requiere procesos definidos primeroLas pymes que implementan IA exitosamente comparten un factor común: documentan procesos antes de automatizar. El 95% de…
El Ecosistema Startup · Aug 23 Enhanced Games pierde US$62M: cómo confundir viralidad con unidad económicaEnhanced Group reportó pérdidas de US$62 millones en Q2 2026 tras los Enhanced Games en Las Vegas, revelando que los ing…
Bias & Framing
⚖
Article presents Chilean vaccine research with promotional framing, emphasizing national achievement and scientific breakthrough without critical examination or counterbalancing perspectives.
Bias Direction
center-right
Confidence
MED
Nationalistic pride framing combined with scientific achievement narrative. The article emphasizes Chilean institutional involvement (Universidad de Chile, local spin-off, Chilean marine ingredient) and positions the research as a significant breakthrough, using dramatic language ('kamikaze cells') to enhance appeal.
células inmunes 'kamikaze'
transformándose en presentadores de antígenos
indispensables para la eficacia
hallazgo
demuestra
revolucionario descubrimiento
Skeptical scientific voices or limitations of the study
Timeline to human trials and realistic commercialization prospects
Comparison with competing melanoma vaccine approaches globally
Potential risks or side effects discussed
Independent expert commentary from outside the research team
Funding sources and potential conflicts of interest
Regulatory pathway challenges for vaccine approval
Geopolitical Impact
🌎
Chilean melanoma vaccine breakthrough has minimal geopolitical impact; primarily a domestic biomedical advancement with potential commercial applications in oncology markets.
Escalation Risk
low
Confidence
HIGH
Chile
Latin America
Global pharmaceutical/biotech markets
Strengthens Chile's position in biotech innovation and medical research, potentially enhancing regional scientific soft power. Demonstrates capacity for high-value pharmaceutical IP development, though impact remains limited to commercial/scientific spheres rather than strategic geopolitics.
Economic Lens
📈
Chilean biotech firm Oncobiomed advances TRIMELVax melanoma vaccine with patented discovery that neutrophils are essential immune cells for efficacy, positioning Chile as oncology innovation hub with commercial potential.
Market Signal
bullish
Confidence
MED
Biotechnology and pharmaceutical manufacturing
Healthcare and oncology services
Medical research and development
Intellectual property and licensing
Medical tourism and healthcare exports
Potential future access to advanced melanoma treatment option; reduced healthcare costs if vaccine proves effective and reaches market; improved survival outcomes for melanoma patients; increased demand for specialized oncology services in Chile.
Government may increase R&D funding for biotech sector; potential regulatory fast-track for clinical trials; IP protection strengthening; possible tax incentives for biotech spinoffs; international collaboration agreements; healthcare system preparation for new cancer treatment protocols.